返回 Agenda
Session Chair(s)
Andre Daniels, MD, MS
Executive Director, Global Regulatory Affairs and Safety
Amgen, Inc., United States
Speaker(s)
Detection, Evaluation, Mitigation and Reporting of Safety Issues through the Product Life Cycle
Joanna Haas, MD, MSC, FACP, FISPE
Haas and Partners LLC, United States
Founding Partner
The Growing Use of Observational Studies in Risk Management Strategy
J. Michael Sprafka, PHD, MPH
Amgen Inc., United States
Executive Director, General Medicine, Inflammation & Bone TA Lead
Methods and Challenges in Evaluating Risk Management and Risk Minimization Programs
Paul J. Seligman, MD, MPH
Amgen Inc., United States
Executive Director, Global Regulatory and R&D Policy